Tender procurement

Sichuan Guangda Pharmaceutical Overall Relocation and Expansion Project 5# Production Plant Construction General Contracting Bidding Announcement


Release time:

2020-07-15

    Our company intends to conduct bidding for the following procurement project. We welcome units with good bank credit and financial status, meeting qualification requirements, and having similar project achievements to participate in the bidding. The relevant matters of this project are announced as follows:
 
 
1. Introduction to the Bidding Project
 
 
(1) Project Name: Sichuan Guangda Pharmaceutical Overall Relocation and Expansion Project 5# Production Plant Construction General Contracting Project
 
(2) Construction Unit: Sichuan Guangda Pharmaceutical Co., Ltd.
 
(3) Project Implementation Location: New Plant of Sichuan Guangda Pharmaceutical Co., Ltd., Section 2, East Third Ring Road, Pengzhou City, Sichuan Province

 

(4) Procurement Content (Scope of Work): A Class A production plant construction project, including water, electricity, construction, structure, HVAC, fire protection, and other specialties. This project covers an area of 1878.64㎡, with a total construction area of 6325.95㎡, a four-story reinforced concrete frame structure building above ground, with a first-floor height of 6.9m, second-floor height of 7.2m, third-floor height of 4.5m, fourth-floor height of 4.5m, and a height of 3.75m for the roof stairwell and machine room, with a building height of 23.72m.

 

(5) Quality Requirements for this Bidding Project: Ensure that the project quality first pass rate is 100%, in accordance with the current national engineering quality evaluation standards and the technical requirements of the party.

 

(6) Equipment Delivery Period (Project Duration): 180 days

 

 
2. Qualification Requirements for Bidders and Required Submission Materials
 
 
1. Legal enterprises with valid business licenses and credentials, capable of independently assuming civil liability, with last year's operating income not less than 150 million yuan, able to send a technical person to the project site for inspection and technical inquiries within the specified time; enterprises applying for engineering projects should have a Class 1 or above construction general contracting qualification.
2. Submission materials required for registration: Legal authorization (entrustment) letter, copies of the legal person's and authorized person's ID cards, copies of the business license, copies of the qualification certificate, copies of contracts, annual financial statements, contact person and communication methods (the above copies must be stamped with the official seal of the unit).
 
 
3. Registration and Qualification Pre-Review
 
 
(1) Registration Time: Deadline is 10 days from the date of posting.
 
(2) Registration Method: Send the registration materials for the Sichuan Guangda Pharmaceutical Overall Relocation and Expansion Project 5# Production Plant Construction General Contracting Project to the dedicated bidding registration email.
 
(3) Dedicated Bidding Registration Email: gdxc@livzon.cn
 
(4) Contact Person's Tel: Zhang Bin  13882039199
 
(5) Qualification Pre-Review: Our company will conduct a qualification pre-review based on the bidder's registration materials, and will provide written feedback and confirm the bidding qualifications for potential bidders that meet the requirements. The acquisition of bidding documents and the bidding deadline will be notified separately by the bidder.
 
(6) Qualified bidders should register as qualified suppliers in the Lizhu Group SRM system. For details, see the "Supplier Registration Operation Manual" on the official website (http://srm.livzon.cn/).
 
 
4. This bidding is supervised by the Group Risk Management Headquarters, and the relevant contact information is as follows:
 
 
Contact: Wang Wei, Li Yan; Fixed Tel: 0756-8135383, 7238615 
 
Mobile: 13702319181, 13926901091; 
 
Email: wangwei@livzon.cn, liyan@livzon.cn
 
 
 
                                                   
 
Sichuan Guangda Pharmaceutical Co., Ltd.
                                                      
July 13, 2020

Previous Page

Next Page